--- title: "Top 10 US Stock Gainers (8.19)" type: "News" locale: "en" url: "https://longbridge.com/en/news/296405270.md" description: "Moderna(MRNA) rose 176.97%, with a trading turnover 28.6 Billion USD, and a year-to-date rose 491.3%. Hyperliquid Strategies(PURR) rose 30.42%, with a trading turnover 516.2 Million USD, and a year-to-date rose 163.8%. Maravai LifeSciences(MRVI) rose 25.78%, with a trading turnover 109.3 Million USD, and a year-to-date rose 122.2%." datetime: "2026-08-19T22:00:51.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296405270.md) - [en](https://longbridge.com/en/news/296405270.md) - [zh-HK](https://longbridge.com/zh-HK/news/296405270.md) generator: "portal-rs" --- # Top 10 US Stock Gainers (8.19) NASDAQ Composite Index has rose 0.16%, with a year-to-date rose 13.3%; S&P 500 has rose 0.21%, with a year-to-date rose 12.6%; Dow Jones Industrial Average has rose 0.22%, with a year-to-date rose 11.2%. Moderna(MRNA) rose 176.97%, with a trading turnover 28.6 Billion USD, and a year-to-date rose 491.3%. Hyperliquid Strategies(PURR) rose 30.42%, with a trading turnover 516.2 Million USD, and a year-to-date rose 163.8%. Maravai LifeSciences(MRVI) rose 25.78%, with a trading turnover 109.3 Million USD, and a year-to-date rose 122.2%. ### Related Stocks - [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md) - [PURR.US](https://longbridge.com/en/quote/PURR.US.md) - [MRVI.US](https://longbridge.com/en/quote/MRVI.US.md) - [TEM.US](https://longbridge.com/en/quote/TEM.US.md) - [TWST.US](https://longbridge.com/en/quote/TWST.US.md) - [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md) - [SOC.US](https://longbridge.com/en/quote/SOC.US.md) - [EL.US](https://longbridge.com/en/quote/EL.US.md) - [HYMC.US](https://longbridge.com/en/quote/HYMC.US.md) - [EYPT.US](https://longbridge.com/en/quote/EYPT.US.md) ## Related News & Research - [Moderna Stock (MRNA) Slides 3% on Plans for a $2B Private Placement](https://longbridge.com/en/news/297195128.md) - [This Moderna Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday](https://longbridge.com/en/news/297353340.md) - [Moderna plans private placement of $2 billion convertible senior notes offering](https://longbridge.com/en/news/297176043.md) - [After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)](https://longbridge.com/en/news/296918567.md) - [BioNTech to terminate mid-stage trial of mRNA cancer vaccine](https://longbridge.com/en/news/297334714.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**